IDEAYA Biosciences (IDYA) Assets (2018 - 2026)

IDEAYA Biosciences has reported Assets for 9 years, with the latest figure at $1.0 billion in Q1 2026.

• Quarterly Assets fell 6.39% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (down 6.39% YoY) and the FY2025 annual result came in at $1.1 billion, down 1.31% from the prior year.
• Assets slipped to $1.0 billion in Q1 2026 per IDYA's latest filing, from $1.1 billion in the prior quarter.
• Over five years, Assets peaked at $1.2 billion in Q3 2024 and troughed at $338.0 million in Q2 2022.
• A 5-year average of $784.5 million and a median of $961.5 million in 2024 frame the typical range for Assets.
• The sharpest annual moves came in 2024 and 2026: Assets surged 163.62% in 2024, then dropped 6.39% in 2026.
• Over 5 years, Assets stood at $388.0 million in 2022, then jumped by 67.36% to $649.3 million in 2023, then surged by 73.12% to $1.1 billion in 2024, then slipped by 1.31% to $1.1 billion in 2025, then retreated by 7.12% to $1.0 billion in 2026.
• According to Business Quant data, Assets over the past three periods registered $1.0 billion, $1.1 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.